Author： Ghaith Ola El-Halabi Mustapha Hashash Jana G Sharara Ala I
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.10, 2010-10, pp. : 1161-1178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Irritable Bowel Syndrome: New Agents Targeting Serotonin Receptor Subtypes
By De Ponti F.
Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. :
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. :
Quality of Life in Irritable Bowel Syndrome
PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. :